Thu 05/06/2021 13:14 PM
Relevant Document:
2019 Financial Report
Direct lenders and banks are circling the sale of Italian clinical laboratory and diagnostic services provider Bianalisi with leverage levels expected in the range of 4.5x to 5x, sources said. Rothchild is running the process.
The company is being marketed off projected EBITDA in 2021 of €26.7 million and could reach a valuation of about €320 million based on a 12x multiple, sources said. The company's EBITDA in 2020 was about €19.7...
This article is an example of the content you may receive if you subscribe to a product of Reorg Research, Inc. or one of its affiliates (collectively, “Reorg”). The information contained herein should not be construed as legal, investment, accounting or other professional services advice on any subject. Reorg, its affiliates, officers, directors, partners and employees expressly disclaim all liability in respect to actions taken or not taken based on any or all the contents of this publication. Copyright © 2024 Reorg Research, Inc. All rights reserved.